Initiatives and programs
We're working on a range of policy initiatives, programs and campaigns to help improve your health and the health of all Australians.
Signed by all Australian governments, the 2020–25 Addendum to National Health Reform Agreement (NHRA) aims to improve health outcomes for all Australians and ensure our health system is sustainable.
Electronic prescribing is now widely available. It provides an option for prescribers and their patients to use an electronic prescription as an alternative to paper prescriptions. Paper prescriptions are still available.
The Medical Research Future Fund (MRFF) is a $20 billion long-term investment supporting Australian health and medical research. Our 10-year plan for the MRFF supports life-saving and job-creating medical research, reaffirming Australia’s reputation as a global leader in the field.
The MBS Continuous Review will ensure the MBS continues to support high-quality care, remains flexible, and stays up to date. We do this through a process of ongoing expert reviews.
The MBS Review considered how MBS items could be better aligned with contemporary clinical evidence and practice, to improve health outcomes. The review ran from 2015 to 2020. The Australian Government is progressively considering and implementing the recommendations.
This initiative gives general practitioners (GPs) an opportunity to self-assess their pathology referral process using data relevant to them. It supports quality use of pathology requests, or other alternatives if they are a better choice.
The Value in Prescribing (ViP) Program funds resources, tools and interventions. These support specialist health professionals and patients in using immunoglobulin products and alternatives to biological disease-modifying anti-rheumatic drugs (bDMARDs).